Clinical Trials Browser

Completed × GSK2141795 × Plasma cell × Clear all

NCT01989598 2022-03-02

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

25 enrolled 11 charts

Multiple Myeloma